If a patient already taking chaemotherapy treatment suffered with severe jaundice what will be the treatment?

The treatment for severe jaundice in a patient already receiving chemotherapy will depend on the underlying cause of the jaundice and the patient's overall health condition. Here are some potential treatment options:

1. Underlying Cause Management: The first step is to identify and address the underlying cause of the jaundice. This may involve:

- Discontinuing Chemotherapy: If the chemotherapy is causing or contributing to the jaundice, the doctor may temporarily discontinue or adjust the chemotherapy regimen.

- Treating Infections: If an infection (e.g., viral hepatitis) is causing the jaundice, the doctor will prescribe appropriate antiviral or antibiotic medications.

- Managing Obstruction: If the jaundice is due to biliary obstruction (blocked bile ducts), the doctor may recommend endoscopic retrograde cholangiopancreatography (ERCP) to relieve the obstruction. This procedure involves inserting a small camera and instruments into the bile ducts to remove any blockages.

2. Liver Support: Medications and therapies may be provided to support liver function and reduce the effects of jaundice:

- Vitamin K: Severe jaundice can lead to low levels of vitamin K and impaired blood clotting. Vitamin K supplements may be given to correct this issue.

- Antihistamines: These medications can help manage itching associated with jaundice.

- Cholestyramine: This medication may be prescribed to bind to bile acids in the intestines, reducing the absorption of these substances and helping relieve itching.

3. Diet Modification: A healthy diet that is low in fat and high in fiber can help reduce the strain on the liver and support its function.

4. Supportive Care: Other measures may be taken to support the patient's overall health and well-being during this time:

- Hydration: Adequate fluid intake is essential to support the liver and kidneys in removing toxins from the body.

- Rest: Getting adequate rest can help the body's natural healing processes.

5. Close Monitoring: The patient's condition will be closely monitored, including blood tests and liver function assessments, to track the progress of the treatment and make any necessary adjustments.

It's important to note that the specific treatment approach will vary based on the patient's individual circumstances and the underlying cause of the jaundice. The patient's healthcare team, including the oncologist and hepatologist, will collaborate to develop a personalized treatment plan that addresses both the jaundice and the ongoing chemotherapy treatment.